DOCSLIB.ORG

Down Regulated in Immortal Sccs but Up-Regulated in Senescent Epithelial

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Down Regulated in Immortal Sccs but Up-Regulated in Senescent Epithelial Figure S1. Comparison of published epithelial cell senescence gene expression profiles with the gene expression changes >2 fold between normal mucosa and mortal and immortal SCCs identified by SAM analysis (FDR<1%) Normal mucosa Senescence changes >3 fold versus immortal SCC 3324* 165 in normal oral mucosa (Data from Fig. 3 (Kang et al. 3** Exp Cell Res, 287: 272-281, 2003.) 33 17*** 263 Normal mucosa versus mortal SCC *4 genes: Down regulated in immortal SCCs but up-regulated in senescent epithelial cells: CEACAM6, DSG3, MMP1 Up-regulated in immortal SCCs but down-regulated in senescent epithelial cells: SMARCA3 **3 genes: Up-regulated both in mortal SCCs and senescent epithelial cells: MMP10 Down-regulated both in mortal SCCs and senescent epithelial cells: BUB1, CDKN3 ***17 genes: Up-regulated both in mortal SCCs and senescent epithelial cells: BMPR2, CDKN2B, COL1A1, COL1A2, COL6A1, CXCL3, CYPB1, FN1, IGFBP3, Down-regulated both in mortal SCCs and senescent epithelial cells: BIRC5, CCNA2, CCNB1, CCNB2, CENPF, NRG1, PCNA, SKP2 Table S1 Clinical characteristics of tumours Biopsy Patient Culture NameSite lesion stage smoking age sex Lifespan (PDs) Normal mucosa FNB3 (N3)BM none N/A n 45 M 25.5 FNB5 (N5)BM none N/A n 40 F 20 FNB6 (N6)BM none N/A n 35 F >24 NB9 (N9)BM normal adjacent N/Ay 53 M >17 Dysplasias D6PT Leukoplakia mod/severe y 55 M 25 D8FOM Leukoplakia mild/mod y 71 M 9 D25FOM Leukoplakia severe y 58 M 28 D30FOM Leukoplakia mild y 52 M 30 D41RM Leukoplakia mild n 55 F 3.5 D47FOM Leukoplakia mod y 82 F 20 D48FOM/VT Leukoplakia mod/severe y 62 F 25.5 D17 (EL)BM Leukoplakia mild/mod y 61 M 61 E1TUU Erythroplakia CIS M 24 E2ALV Erythroplakia CIS U U M 17 E4LT Erythroplakia CIS U 65 F 41 E5LT Erythroplakia severe U 61 M 31 D4 FOM/VTLeukoplakia CIS y 51 M >100 D9VT Leukoplakia mild/mod n 84 M >100 D34LT Leukoplakia mod n 54 F >100 D38LT Leukoplakia mild n 55 F >100 D19LT erythroleukoplakia Severe/CIS y 53 M >100 D20LT Leukoplakia moderate n 50 M >100 D35FOM/VT erythroleukoplakia Severe/CIS y 68 M >100 SCCs BICR 30 (P30)LNX Carcinoma T4N1M0 y U M 17 BICR 66 (P66)RM/T Carcinoma T2N0M0 y 56 M 37 BICR 80 (P80)LNX Carcinoma T4N2CM0 y 71 M 62 BICR 1 (P1)TU68 Carcinoma T2N0M0 M 15 BICR 73 (P73)Ty49 Carcinoma T2N0M0 M 10 BICR 25 (P25)FOM Carcinoma T2N0M0 y 72 M 15 BICR 3 (P3)ALV Carcinoma T2N0M0 y 56 F >130 BICR 31 (P31)TUU Carcinoma T4N2BM0 M >130 BICR 56 (P56)Ty59 Carcinoma T4N1M0 F >130 BICR 68 (P56)BT Carcinoma T4N0M0 n 75 F >130 T4 (P4)FOM Carcinoma T4N0 U U F >130 T5 (P5)BM Carcinoma T2N2 Y 59 F >130 BICR 78 (P78)ALV Carcinoma T4N1M0 U 68 M >130 BICR 63 (P63)T Carcinoma T2N2BM0 y 70 M >130 BICR 6 (P6)HP Carcinoma T4N1M0 U U M >130 BICR10 (R10)BM Recurrence T4N0M0 n 84 F >130 BICR16 (R16)Ty49 Recurrence T2N0M0 M >130 BICR82 (R82)MX Recurrence N.D. y 48 M >130 BICR 7 (CR7)TY43 Carcinoma T4N2BM0 M 43 (crisis) LN Metastases BICR 37 (M37)Primary:T Metastasis T4N2CM0* U U F 32 BICR 22 (M22)Primary:T Metastasis T4N3M0* U 88 M >130 BICR 18 (M18)Primary:LN Metastasis T4N1M0*UU U >130 The tumor names given in brackets are the abbreviations used in the text Key: ALV, alveolus; BM, buccal mucosa; BT, base of tongue; CIS, carcinoma in situ; FOM, floor of mouth; HP, hypopharynx; LN, lymph node; LNX, larynx; LT, lateral tongue; MX, maxilla; N/A, not applicable; N.D., not determined; normal adjacent, apparently normal mucosa from patient with SCC; PT, posterior tongue; RM, retromolar trigone; T, tongue; U, information not available; VT, ventral tongue; *, staging of primary SCC. Table S2. Gene expression changes common to mortal and immortal SCCs Average expression levels (AV) are given from the microarray data with standard deviations (SD). carcinomas normal mortal immortal recurrence Common Genbank Systematic AV SD AV SD AV SD AV SD ASS NM_000050 207076_s_at 138 53 767 424 760 708 794 274 CKB NM_001823 200884_at 99 25 327 104 243 82 347 92 CUGBP2 U69546 202157_s_at 261 34 112 34 76 11 83 5 CYP27B1 NM_000785 205676_at 657 118 306 171 196 86 163 62 FOXQ1 AI676059 227475_at 134 39 280 89 384 199 622 394 ITM2A; E25A; AL021786 202746_at 43 17 16 8 17 19 11 1 MO25 NM_016289 217873_at 1240 191 620 195 696 268 344 114 MTR3 AF131796 231916_at 123 30 54 45 38 15 56 22 PLCD4 BC006355 224505_s_at 187 23 91 32 77 4 82 3 SIX1 N79004 228347_at 58 5 168 73 144 84 147 35 THBS2 NM_003247 203083_at 233 104 92 14 117 69 63 8 Table S3. Genes consistently 5-fold different in expression between mortal and immortal SCCs by SAM (FDR<1%) AF1Q 211071_s_at NM_006818 ALDH1A3 203180_at NM_000693 ANLN 222608_s_at NM_018685 ASNS 205047_s_at NM_133436 ASPM 219918_s_at NM_018123 AURKB 209464_at NM_004217 BF 202357_s_at NM_001710 BIRC5 202095_s_at NM_001168 BPGM 203502_at NM_001724 BUB1B 203755_at NM_001211 C10orf3 218542_at NM_018131 C1orf10 220090_at NM_016190 C3 217767_at NM_000064 CCL20 205476_at NM_004591 CCNA2 203418_at NM_001237 CCNB1 214710_s_at NM_031966 CCNB2 202705_at NM_004701 CD24 209772_s_at NM_013230 CDC2 203214_x_at NM_001786 CDC20 202870_s_at NM_001255 CDC6 203968_s_at NM_001254 CDCA7 224428_s_at NM_031942 CDKN2B 236313_at NM_078487 CDKN3 209714_s_at NM_005192 CDSN 206193_s_at NM_001264 CEACAM1 209498_at NM_001712 CEACAM5 201884_at NM_004363 CEACAM6 203757_s_at NM_002483 CENPF 207828_s_at NM_005196 CKS1B 201897_s_at NM_001826 CKS2 204170_s_at NM_001827 COL1A1 202310_s_at NM_000088 COL1A2 202403_s_at NM_000089 COL6A3 201438_at NM_004369 CSPG2 221731_x_at NM_004385 CXCL1 204470_at NM_001511 CXCL5 214974_x_at NM_002994 CXCL6 206336_at NM_002993 DEFB1 210397_at NM_005218 DHRS9 224009_x_at NM_005771 DLG7 203764_at NM_014750 DSC2 204751_x_at NM_004949 ECG2 223720_at NM_032566 ECM1 209365_s_at NM_004425 EHF 225645_at NM_012153 EPS8L1 221665_s_at NM_133180 FAP 209955_s_at NM_004460 FEN1 204768_s_at NM_004111 FKBP1B 206857_s_at NM_054033 FLJ32029 229256_at NM_173582 FN1 216442_x_at NM_002026 FOXM1 202580_x_at NM_021953 FYB 227266_s_at NM_001465 G0S2 213524_s_at NM_015714 GABRP 205044_at NM_014211 HEC 204162_at NM_006101 HES2 231928_at AK091122 HIST2H2AA 214290_s_at NM_003516 HMGB2 208808_s_at NM_002129 HOP 211597_s_at NM_032495 HOXD10 229400_at NM_002148 HSD11B1 205404_at NM_181755 IL1RN 212657_s_at NM_173843 IL8 202859_x_at NM_000584 INSR 227432_s_at NM_000208 IVL 214599_at NM_005547 KIAA0101 202503_s_at NM_014736 KIAA0186 206102_at NM_021067 KIAA1359 231941_s_at AB037780 KLK5 222242_s_at AF243527 KLK6 204733_at NM_002774 KLK7 239381_at NM_005046 KRT13 207935_s_at NM_153490 KRT19 201650_at NM_002276 KRT23 218963_s_at NM_015515 KRT4 213240_s_at NM_002272 KRT7 209016_s_at NM_005556 LCN2; NGAL 212531_at NM_005564 LIPG 219181_at NM_006033 MAC30 212279_at NM_014573 MAD2L1 203362_s_at NM_002358 MAL 204777_s_at NM_002371 MAP17 219630_at NM_005764 MCM2 202107_s_at NM_004526 MCM4 222037_at NM_005914 MCM5 216237_s_at NM_006739 MCM7 208795_s_at NM_182776 MKI67 212022_s_at NM_002417 MMP1 204475_at NM_002421 MMP10 205680_at NM_002425 MMP7 204259_at NM_002423 MYL9 201058_s_at NM_006097 NICE-1 220620_at NM_019060 NMES1 223484_at NM_032413 NTN4 223315_at NM_021229 NUSAP1 218039_at NM_016359 OSF-2 210809_s_at NM_006475 PCNA 201202_at NM_002592 Pfs2 221521_s_at NM_016095 PI3 203691_at NM_002638 PIGR 226147_s_at AA838075 PLAB 221577_x_at NM_004864 PLAT 201860_s_at NM_000930 PMSCL1 213226_at NM_005033 PPBP 214146_s_at NM_002704 PRC1 218009_s_at NM_003981 PTGS1 215813_s_at NM_000962 PTGS2 204748_at NM_000963 RAMP 218585_s_at NM_016448 RARRES1 206391_at NM_002888 RBPMS 209488_s_at NM_006867 RCP 225177_at NM_025151 RFC3 204127_at NM_002915 RFC4 204023_at NM_002916 RHCG 219554_at NM_016321 RPS4Y 201909_at NM_001008 RRM2 209773_s_at NM_001034 S100A7 205916_at NM_002963 S100A8 202917_s_at NM_002964 S100A9 203535_at NM_002965 S100P 204351_at NM_005980 SAA2 208607_s_at NM_030754 SAT 213988_s_at NM_002970 SCEL 206884_s_at NM_144777 SCGB1A1 205725_at NM_003357 SDP35 222958_s_at NM_017779 SERPINA3 202376_at NM_000624 SERPINB1 212268_at NM_030666 SERPINB3 209719_x_at NM_006919 SIAT7A 227725_at NM_018414 SLC6A14 219795_at NM_007231 SLPI 203021_at NM_003064 SMC2L1 204240_s_at NM_006444 SMC4L1 201664_at NM_005496 SNRPN 201522_x_at NM_022807 SPINK5 205185_at NM_006846 SPRR1A 213796_at NM_005987 SPRR1B 205064_at NM_003125 SPRR2B 208539_x_at NM_006945 SPRR3 232082_x_at NM_005416 STK6 208079_s_at NM_003158 TAGLN 205547_s_at NM_015996 TCN1 205513_at NM_001062 TGFB2 228121_at NM_003238 TOP2A 201292_at NM_001067 TOPK 219148_at NM_018492 TP53I3 210609_s_at NM_004881 TPX2 210052_s_at NM_012112 TRIM22 213293_s_at NM_006074 TRIP13 204033_at NM_004237 TTK 204822_at NM_003318 TUBA3 209118_s_at NM_006009 TYMS 202589_at NM_001071 UBE1C 229831_at NM_003968 UBE2C 202954_at NM_181802 UHRF1 225655_at NM_013282 UPK1B 210064_s_at NM_006952 VRK1 203856_at NM_003384 ZNF367 229551_x_at NM_153695 ZWINT 204026_s_at NM_032997 Table S4. Gene expression changes associated with dysplasia and SCC immortality Mean SD CV AFFY ID Gene Symbol N (n=4) MD (n=11) MC (n=4) ID (n=7) IC (n=11) N (n=4) MD (n=11) MC (n=4) ID (n=7) IC (n=11) N (n=4) MD (n=11) MC (n=4) ID (n=7) IC (n=11) 222162_s_at ADAMTS1 388 409 638 159 165 68 97 195 46 104 18 24 31 29 63 211071_s_at AF1Q 307 419 1186 101 152 85 132 980 48 96 28 32 83 48 63 203180_at ALDH1A3 1542 4102 4537 538 518 852 1337 2724 376 836 55 33 60 70 162 203722_at ALDH4A1 306 404 243 136 154 43 159 99 34 53 14 39 41 25 34 203404_at ALEX2 151 124 181 50 59 8 28 46 23 52 6 23 26 46 89 206385_s_at ANK3 88 106 92 45 53 24 37 24 16 22 27 35 26 37 41 204244_s_at ASK 36 32 19 77 90 4 8 3 24 47 12 27 18 30 52 202095_s_at BIRC5 290 235 90 540 540 65 95 29 160 152 22 40 32 30 28 219555_s_at BM039
Load more

Recommended publications
  • Dominantly Acting Variants in ARF3 Have Disruptive Consequences on Golgi Integrity and Cause Microcephaly Recapitulated in ZebraSh
    Dominantly acting variants in ARF3 have disruptive consequences on Golgi integrity and cause microcephaly recapitulated in zebrash Giulia Fasano Ospedale Pediatrico Bambino Gesù Valentina Muto Ospedale Pediatrico Bambino Gesù Francesca Clementina Radio Genetic and Rare Disease Research Division, Bambino Gesù Children's Hospital IRCCS, Rome, Italy https://orcid.org/0000-0003-1993-8018 Martina Venditti Ospedale Pediatrico Bambino Gesù Alban Ziegler Département de Génétique, CHU d’Angers Giovanni Chillemi Tuscia University https://orcid.org/0000-0003-3901-6926 Annalisa Vetro Pediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children’s Hospital, University of Florence Francesca Pantaleoni https://orcid.org/0000-0003-0765-9281 Simone Pizzi Bambino Gesù Children's Hospital Libenzio Conti Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome https://orcid.org/0000-0001-9466-5473 Stefania Petrini Bambino Gesù Children's Hospital Simona Coppola Istituto Superiore di Sanità Alessandro Bruselles Istituto Superiore di Sanità https://orcid.org/0000-0002-1556-4998 Ingrid Guarnetti Prandi University of Pisa, 56124 Pisa, Italy Balasubramanian Chandramouli Super Computing Applications and Innovation, CINECA Magalie Barth Céline Bris Département de Génétique, CHU d’Angers Donatella Milani Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Angelo Selicorni ASST Lariana Marina Macchiaiolo Ospedale Pediatrico Bambino Gesù, IRCCS Michaela Gonantini Ospedale Pediatrico Bambino Gesù, IRCCS Andrea Bartuli Bambino Gesù Children's
    [Show full text]
  • BACE1 Elevation Engendered by GGA3 Deletion Increases Β-Amyloid
    Kim et al. Molecular Neurodegeneration (2018) 13:6 DOI 10.1186/s13024-018-0239-7 RESEARCH ARTICLE Open Access BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice WonHee Kim1,2, Liang Ma1,2, Selene Lomoio1,2, Rachel Willen1,2, Sylvia Lombardo1,2, Jinghui Dong2, Philip G. Haydon2 and Giuseppina Tesco1,2* Abstract Background: β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the rate-limiting enzyme in the production of amyloid beta (Aβ), the toxic peptide that accumulates in the brains of Alzheimer’s disease (AD) patients. Our previous studies have shown that the clathrin adaptor Golgi-localized γ-ear-containing ARF binding protein 3 (GGA3) plays a key role in the trafficking of BACE1 to lysosomes, where it is normally degraded. GGA3 depletion results in BACE1 stabilization both in vitro and in vivo. Moreover, levels of GGA3 are reduced and inversely related to BACE1 levels in post-mortem brains of AD patients. Method: In order to assess the effect of GGA3 deletion on AD-like phenotypes, we crossed GGA3 −/− mice with 5XFAD mice. BACE1-mediated processing of APP and the cell adhesion molecule L1 like protein (CHL1) was measured as well as levels of Aβ42 and amyloid burden. Results: In 5XFAD mice, we found that hippocampal and cortical levels of GGA3 decreased while BACE1 levels increased with age, similar to what is observed in human AD brains. GGA3 deletion prevented age-dependent elevation of BACE1 in GGA3KO;5XFAD mice. We also found that GGA3 deletion resulted in increased hippocampal levels of Aβ42 and amyloid burden in 5XFAD mice at 12 months of age.
    [Show full text]
  • DNA Damage Triggers Tubular Endoplasmic Reticulum Extension to Promote Apoptosis by Facilitating ER-Mitochondria Signaling
    www.nature.com/cr www.cell-research.com ARTICLE OPEN DNA damage triggers tubular endoplasmic reticulum extension to promote apoptosis by facilitating ER-mitochondria signaling Pengli Zheng1,2, Qingzhou Chen1, Xiaoyu Tian1, Nannan Qian1,3, Peiyuan Chai1, Bing Liu1,4, Junjie Hu 5,6, Craig Blackstone2, Desheng Zhu7, Junlin Teng 1 and Jianguo Chen1,4 The endoplasmic reticulum (ER) is composed of the nuclear envelope, perinuclear sheets and a peripheral tubular network. The peripheral ER and mitochondria form tight contacts at specific subdomains, which coordinate the functions of the two organelles and are required for multiple cellular processes such as Ca2+ transfer and apoptosis. However, it is largely unknown how ER morphology and ER-mitochondria signaling are dynamically regulated under different physiological or pathological conditions such as DNA damage. Here we show that the peripheral, tubular ER undergoes significant extension in response to DNA damage, and that this process is dependent on p53-mediated transcriptional activation of the ER-shaping proteins REEP1, REEP2 and EI24 (alias PIG8). This promotes the formation of ER-mitochondria contacts through EI24 and the mitochondrial outer membrane protein VDAC2, facilitates Ca2+ transfer from ER to mitochondria and promotes DNA damage-induced apoptosis. Thus, we identify a unique DNA damage response pathway involving alterations in ER morphology, ER-mitochondria signaling, and apoptosis. Cell Research (2018) 28:833–854; https://doi.org/10.1038/s41422-018-0065-z INTRODUCTION transfer with high efficiency from the ER to mitochondria, which The endoplasmic reticulum (ER) is the largest membranous is necessary for mitochondrial metabolism.16 However, dramati- organelle and performs essential roles in protein synthesis and cally increased ER-mitochondria Ca2+ flux triggers apoptosis by secretion, Ca2+ homeostasis, and lipid metabolism.
    [Show full text]
  • Ei24) Reduced Cell Proliferation and Aggregate-Size in Dictyostelium Discoideum NEHA GUPTA and SHWETA SARAN*
    Int. J. Dev. Biol. 62: 273-283 (2018) https://doi.org/10.1387/ijdb.170327ss www.intjdevbiol.com Deletion of etoposide-induced 2.4 kb transcript (ei24) reduced cell proliferation and aggregate-size in Dictyostelium discoideum NEHA GUPTA and SHWETA SARAN* School of Life Sciences, Jawaharlal Nehru University, New Delhi, India ABSTRACT The etoposide-induced 2.4 kb transcript (ei24) gene is induced both by p53 and etoposide, an anti-cancer tumour drug. There is no p53 gene present in Dictyostelium discoideum. Thus, the functions of ei24 in the absence of p53 were analysed. Both overexpressor (ei24OE) and knockout (ei24-) mutants were made to study its role during growth, development and differentiation. Addi- tionally, cell cycle and its response to DNA-damage were also analysed. We identified, characterized and elucidated the functions of the ei24 gene in Dictyostelium. In silico analyses demonstrated the conservation across eukaryotes and in situ hybridization showed it to be prestalk-specific.ei24 - cells showed reduced cell proliferation and cell-cohesive properties, ultimately forming small-sized ag- gregates that developed into miniature and stalky fruiting bodies. The ei24OE cells formed fruiting bodies with engorged or double-decker type sori with short stalks. The ei24- cells showed reduced cAMP signalling with lower intracellular cAMP levels resulting in diminished migration of cells along cAMP gradients. Deletion of ei24 resulted in mis-expression of prestalk-specific markers. Cell cycle analysis revealed an increased bias towards the stalk-pathway by ei24- cells and vice-versa for ei24OE cells. EI24 in Dictyostelium functions even in the absence of p53 and is induced in response to both UV-radiation and etoposide treatments.
    [Show full text]
  • NIH Public Access Author Manuscript Pharmacogenet Genomics
    NIH Public Access Author Manuscript Pharmacogenet Genomics. Author manuscript; available in PMC 2012 September 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Pharmacogenet Genomics. 2011 September ; 21(9): 607–613. doi:10.1097/FPC.0b013e3283415515. PharmGKB summary: very important pharmacogene information for PTGS2 Caroline F. Thorna, Tilo Grosserc, Teri E. Kleina, and Russ B. Altmana,b aDepartment of Genetics, Stanford University Medical Center, Stanford, California bDepartment of Bioengineering, Stanford University Medical Center, Stanford, California cInstitute for Translational Medicine and Therapeutics, University of Pennsylvania, Pennsylvania, USA Keywords cyclooxygenase-2; coxibs; non-steroidal anti-inflammatory drugs; pharmacogenomics; PTGS2; rs20417; rs5275; rs689466 Very important pharmacogene: PTGS2 This PharmGKB summary briefly discusses the PTGS2 gene and current understanding of its function, structure, regulation, and pharmacogenomic relevance. We also present three variants with pharmacogenomic significance and highlight the gaps in our knowledge of PTGS2-drug interactions. Overview The PTGS2 gene codes for prostaglandin G/H synthase-2, which catalyses the first two steps in the metabolism of arachadonic acid. Prostaglandin G/H synthase-2 has two active sites, a hydroperoxidase and a cyclooxygenase (COX) site, and is colloquially termed COX-2. The bifunctional enzyme performs the bis-dioxygenation and reduction of arachadonic acid to form prostaglandin (PG)G2 and H2. PGH2 is then converted to other PGs that modulate inflammation, including PGD2, PGE2, PGF2α, PGI2, and thromboxane A2 (This pathway is shown in the Lipid maps database at http://www.lipidmaps.org/data/IntegratedPathways Data/SetupIntegratedPathways.pl? imgsize=730&Mode=RAW2647&DataType=FAEicosanoidsMedia). COX-2 is the target for nonsteroidal anti-inflammatory drugs (NSAIDS) including those that were purposefully designed (pd) to be selective for COX-2 (pdNSAIDs or coxibs).
    [Show full text]
  • Genome-Wide Approach to Identify Risk Factors for Therapy-Related Myeloid Leukemia
    Leukemia (2006) 20, 239–246 & 2006 Nature Publishing Group All rights reserved 0887-6924/06 $30.00 www.nature.com/leu ORIGINAL ARTICLE Genome-wide approach to identify risk factors for therapy-related myeloid leukemia A Bogni1, C Cheng2, W Liu2, W Yang1, J Pfeffer1, S Mukatira3, D French1, JR Downing4, C-H Pui4,5,6 and MV Relling1,6 1Department of Pharmaceutical Sciences, The University of Tennessee, Memphis, TN, USA; 2Department of Biostatistics, The University of Tennessee, Memphis, TN, USA; 3Hartwell Center, The University of Tennessee, Memphis, TN, USA; 4Department of Pathology, The University of Tennessee, Memphis, TN, USA; 5Department of Hematology/Oncology St Jude Children’s Research Hospital, The University of Tennessee, Memphis, TN, USA; and 6Colleges of Medicine and Pharmacy, The University of Tennessee, Memphis, TN, USA Using a target gene approach, only a few host genetic risk therapy increases, the importance of identifying host factors for factors for treatment-related myeloid leukemia (t-ML) have been secondary neoplasms increases. defined. Gene expression microarrays allow for a more 4 genome-wide approach to assess possible genetic risk factors Because DNA microarrays interrogate multiple ( 10 000) for t-ML. We assessed gene expression profiles (n ¼ 12 625 genes in one experiment, they allow for a ‘genome-wide’ probe sets) in diagnostic acute lymphoblastic leukemic cells assessment of genes that may predispose to leukemogenesis. from 228 children treated on protocols that included leukemo- DNA microarray analysis of gene expression has been used to genic agents such as etoposide, 13 of whom developed t-ML. identify distinct expression profiles that are characteristic of Expression of 68 probes, corresponding to 63 genes, was different leukemia subtypes.13,14 Studies using this method have significantly related to risk of t-ML.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Steroid-Dependent Regulation of the Oviduct: a Cross-Species Transcriptomal Analysis
    University of Kentucky UKnowledge Theses and Dissertations--Animal and Food Sciences Animal and Food Sciences 2015 Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis Katheryn L. Cerny University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Cerny, Katheryn L., "Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis" (2015). Theses and Dissertations--Animal and Food Sciences. 49. https://uknowledge.uky.edu/animalsci_etds/49 This Doctoral Dissertation is brought to you for free and open access by the Animal and Food Sciences at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Animal and Food Sciences by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]
  • Figure S1. Representative Report Generated by the Ion Torrent System Server for Each of the KCC71 Panel Analysis and Pcafusion Analysis
    Figure S1. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. A Figure S1. Continued. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. B Figure S2. Comparative analysis of the variant frequency found by the KCC71 panel and calculated from publicly available cBioPortal datasets. For each of the 71 genes in the KCC71 panel, the frequency of variants was calculated as the variant number found in the examined cases. Datasets marked with different colors and sample numbers of prostate cancer are presented in the upper right. *Significantly high in the present study. Figure S3. Seven subnetworks extracted from each of seven public prostate cancer gene networks in TCNG (Table SVI). Blue dots represent genes that include initial seed genes (parent nodes), and parent‑child and child‑grandchild genes in the network. Graphical representation of node‑to‑node associations and subnetwork structures that differed among and were unique to each of the seven subnetworks. TCNG, The Cancer Network Galaxy. Figure S4. REVIGO tree map showing the predicted biological processes of prostate cancer in the Japanese. Each rectangle represents a biological function in terms of a Gene Ontology (GO) term, with the size adjusted to represent the P‑value of the GO term in the underlying GO term database.
    [Show full text]
  • UNIVERSITY of CALIFORNIA, IRVINE Combinatorial Regulation By
    UNIVERSITY OF CALIFORNIA, IRVINE Combinatorial regulation by maternal transcription factors during activation of the endoderm gene regulatory network DISSERTATION submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biological Sciences by Kitt D. Paraiso Dissertation Committee: Professor Ken W.Y. Cho, Chair Associate Professor Olivier Cinquin Professor Thomas Schilling 2018 Chapter 4 © 2017 Elsevier Ltd. © 2018 Kitt D. Paraiso DEDICATION To the incredibly intelligent and talented people, who in one way or another, helped complete this thesis. ii TABLE OF CONTENTS Page LIST OF FIGURES vii LIST OF TABLES ix LIST OF ABBREVIATIONS X ACKNOWLEDGEMENTS xi CURRICULUM VITAE xii ABSTRACT OF THE DISSERTATION xiv CHAPTER 1: Maternal transcription factors during early endoderm formation in 1 Xenopus Transcription factors co-regulate in a cell type-specific manner 2 Otx1 is expressed in a variety of cell lineages 4 Maternal otx1 in the endodermal conteXt 5 Establishment of enhancers by maternal transcription factors 9 Uncovering the endodermal gene regulatory network 12 Zygotic genome activation and temporal control of gene eXpression 14 The role of maternal transcription factors in early development 18 References 19 CHAPTER 2: Assembly of maternal transcription factors initiates the emergence 26 of tissue-specific zygotic cis-regulatory regions Introduction 28 Identification of maternal vegetally-localized transcription factors 31 Vegt and OtX1 combinatorially regulate the endodermal 33 transcriptome iii
    [Show full text]
  • A Flexible Microfluidic System for Single-Cell Transcriptome Profiling
    www.nature.com/scientificreports OPEN A fexible microfuidic system for single‑cell transcriptome profling elucidates phased transcriptional regulators of cell cycle Karen Davey1,7, Daniel Wong2,7, Filip Konopacki2, Eugene Kwa1, Tony Ly3, Heike Fiegler2 & Christopher R. Sibley 1,4,5,6* Single cell transcriptome profling has emerged as a breakthrough technology for the high‑resolution understanding of complex cellular systems. Here we report a fexible, cost‑efective and user‑ friendly droplet‑based microfuidics system, called the Nadia Instrument, that can allow 3′ mRNA capture of ~ 50,000 single cells or individual nuclei in a single run. The precise pressure‑based system demonstrates highly reproducible droplet size, low doublet rates and high mRNA capture efciencies that compare favorably in the feld. Moreover, when combined with the Nadia Innovate, the system can be transformed into an adaptable setup that enables use of diferent bufers and barcoded bead confgurations to facilitate diverse applications. Finally, by 3′ mRNA profling asynchronous human and mouse cells at diferent phases of the cell cycle, we demonstrate the system’s ability to readily distinguish distinct cell populations and infer underlying transcriptional regulatory networks. Notably this provided supportive evidence for multiple transcription factors that had little or no known link to the cell cycle (e.g. DRAP1, ZKSCAN1 and CEBPZ). In summary, the Nadia platform represents a promising and fexible technology for future transcriptomic studies, and other related applications, at cell resolution. Single cell transcriptome profling has recently emerged as a breakthrough technology for understanding how cellular heterogeneity contributes to complex biological systems. Indeed, cultured cells, microorganisms, biopsies, blood and other tissues can be rapidly profled for quantifcation of gene expression at cell resolution.
    [Show full text]